Skip to content

Drug interactions

Rasagiline + Selegiline transdermal

Severity: Contraindicated

Rasagiline and Selegiline transdermal: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both are MAO inhibitors, and transdermal selegiline at antidepressant doses inhibits MAO-A and MAO-B. Together they cause excessive MAO inhibition, with risk of hypertensive crisis and serotonin toxicity.

What this interaction means in plain words

Rasagiline and Selegiline transdermal are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Evidence level: Moderate

Why it happens

Additive inhibition of monoamine oxidase, causing loss of enzyme selectivity and accumulation of monoamines.

What to do

Do not use two MAO inhibitors together. Choose one agent and observe a washout of at least 14 days when switching.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rasagiline and Selegiline transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rasagiline with Selegiline transdermal?

MediHelp rates the interaction as contraindicated. Rasagiline and Selegiline transdermal are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Both are MAO inhibitors, and transdermal selegiline at antidepressant doses inhibits MAO-A and MAO-B. Together they cause excessive MAO inhibition, with risk of hypertensive crisis and serotonin toxicity.

How serious is the interaction between Rasagiline and Selegiline transdermal?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not use two MAO inhibitors together. Choose one agent and observe a washout of at least 14 days when switching.

What other medicines interact with Rasagiline?

MediHelp also lists interactions of Rasagiline with, for example, Atomoxetine, Brimonidine, Bupropion-naltrexone. The full list is on the Rasagiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in